New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe
- 1 February 2017
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 40, 84-92
Abstract
No abstract availableKeywords
Funding Information
- European Union
- REITOX Focal Points and their staff
This publication has 19 references indexed in Scilit:
- Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by usersInternational Journal of Drug Policy, 2016
- Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiativesDrug and Alcohol Dependence, 2015
- Emerging Risks Due to New Injecting Patterns in Hungary During Austerity TimesSubstance Use & Misuse, 2015
- Substance Use in the Club Scene of Rome: A Pilot StudyBioMed Research International, 2014
- Debt burden of Greece and HIV among injecting drug usersThe Lancet Infectious Diseases, 2014
- The European Men-Who-Have-Sex-With-Men Internet Survey (EMIS): Design and MethodsSexuality Research and Social Policy, 2013
- Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation? The relationship between Mephedrone, Ecstasy and CocaineEuropean Addiction Research, 2013
- Understanding changes in heroin availability in Europe over time: emerging evidence for a slide, a squeeze and a shockAddiction, 2012
- Alcohol and Drug Prevention in Nightlife Settings: A Review of Experimental StudiesSubstance Use & Misuse, 2011
- Challenges of Reliability and Validity in the Identification and Monitoring of Emerging Drug TrendsSubstance Use & Misuse, 2009